Celularity Inc. vs. Swiss VX Venentherapie und Forschung GmbH – Trademark Extension of Time TTAB Proceeding 90748664

This Extension of Time was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on May 17, 2022 and assigned serial number 90748664 by the TTAB.

Plaintiff:
Celularity Inc. represented by CAMILLE M. MILLER of COZEN O’CONNOR.

Defendant:
Swiss VX Venentherapie und Forschung GmbH represented by SCOTT D. MARTY of BALLARD SPAHR LLP.
Trademark Information: BIOVENA – US Trademark Serial Number 90748664
View Trademark Status at USPTO
View Trademark Documents at USPTO

Prosecution History:
May 17, 2022 – FIRST 30-DAY REQUEST TO EXT TIME TO OPPOSE
May 18, 2022 – EXT GRANTED
July 08, 2022 – ADD’L 60-DAY REQUEST TO EXT TIME TO OPPOSE
July 08, 2022 – EXT GRANTED
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.